These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17353235)

  • 1. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.
    Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA
    Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
    Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
    Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the saposin C domain of the sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice.
    Yoneshige A; Suzuki K; Suzuki K; Matsuda J
    J Neurosci Res; 2010 Aug; 88(10):2118-34. PubMed ID: 20175216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-neuronopathic Gaucher disease due to saposin C deficiency.
    Tylki-Szymańska A; Czartoryska B; Vanier MT; Poorthuis BJ; Groener JA; Ługowska A; Millat G; Vaccaro AM; Jurkiewicz E
    Clin Genet; 2007 Dec; 72(6):538-42. PubMed ID: 17919309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.
    Sun Y; Ran H; Zamzow M; Kitatani K; Skelton MR; Williams MT; Vorhees CV; Witte DP; Hannun YA; Grabowski GA
    Hum Mol Genet; 2010 Feb; 19(4):634-47. PubMed ID: 20015957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saposin C: neuronal effect and CNS delivery by liposomes.
    Chu Z; Sun Y; Kuan CY; Grabowski GA; Qi X
    Ann N Y Acad Sci; 2005 Aug; 1053():237-46. PubMed ID: 16179529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs.
    Zhao Q; Hay N; Morales CR
    Mol Reprod Dev; 1997 Sep; 48(1):1-8. PubMed ID: 9266755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.
    Sun Y; Liou B; Ran H; Skelton MR; Williams MT; Vorhees CV; Kitatani K; Hannun YA; Witte DP; Xu YH; Grabowski GA
    Hum Mol Genet; 2010 Mar; 19(6):1088-97. PubMed ID: 20047948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of saposin C and D in auditory and vestibular function.
    Lustig LR; Alemi S; Sun Y; Grabowski G; Akil O
    Laryngoscope; 2016 Feb; 126(2):452-9. PubMed ID: 26198053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
    Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
    Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice.
    Sun Y; Witte DP; Ran H; Zamzow M; Barnes S; Cheng H; Han X; Williams MT; Skelton MR; Vorhees CV; Grabowski GA
    Hum Mol Genet; 2008 Aug; 17(15):2345-56. PubMed ID: 18480170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants.
    Sun Y; Quinn B; Witte DP; Grabowski GA
    J Lipid Res; 2005 Oct; 46(10):2102-13. PubMed ID: 16061944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.
    Sun Y; Zamzow M; Ran H; Zhang W; Quinn B; Barnes S; Witte DP; Setchell KD; Williams MT; Vorhees CV; Grabowski GA
    Hum Mol Genet; 2013 Jun; 22(12):2435-50. PubMed ID: 23446636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of expression and alternative splicing in the prosaposin gene.
    Cohen T; Ravid L; Altman N; Madar-Shapiro L; Fein A; Weil M; Horowitz M
    Brain Res Mol Brain Res; 2004 Oct; 129(1-2):8-19. PubMed ID: 15469878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
    Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
    Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.
    Cohen T; Auerbach W; Ravid L; Bodennec J; Fein A; Futerman AH; Joyner AL; Horowitz M
    Mol Cell Biol; 2005 Mar; 25(6):2431-40. PubMed ID: 15743835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of prosaposin in the rat nervous system.
    Hosoda Y; Miyawaki K; Saito S; Chen J; Bing X; Terashita T; Kobayashi N; Araki N; Shimokawa T; Hamada F; Sano A; Tanabe H; Matsuda S
    Cell Tissue Res; 2007 Nov; 330(2):197-207. PubMed ID: 17763872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saposin C-LBPA interaction in late-endosomes/lysosomes.
    Chu Z; Witte DP; Qi X
    Exp Cell Res; 2005 Feb; 303(2):300-7. PubMed ID: 15652344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D
    Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
    Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
    Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.